Mariia O. Tregubova

Mariia O. Tregubova

Auto-generated profile, based on publicly available information

Mariia O. Tregubova

ДУ «Національний інститут серцево-судинної хірургії імені М. М. Амосова НАМН України», м. Київ

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2023 in BJR|Open
Verified
Journal Article
Open access
PDF file
AMAhmed Marey
Ahmed Marey
ASAbdelrahman M Saad
Abdelrahman M Saad
BKBenjamin D Killeen
Benjamin D Killeen
CGCatalina Gomez
Catalina Gomez
MTMariia Tregubova
Mariia Tregubova
MUMuhammad Umair
Muhammad Umair
Cardiovascular disease (CVD) is a major cause of mortality worldwide, especially in resource-limited countries with limited access to healthcare resources. Early detection and accurate imaging are vital for managing CVD, emphasizing the significance of patient education. Generative artificial intelligence (AI), including algorithms to synthesize text, speech, images, and combinations thereof given a specific scenario or prompt, offers promising solutions for enhancing patient education. By combining vision and language models, generative AI enables personalized multimedia content generation through natural language interactions, benefiting patient education in cardiovascular imaging. Simulations, chat-based interactions, and voice-based interfaces can enhance accessibility, especially in resource-limited settings. Despite its potential benefits, implementing generative AI in resource-limited countries faces challenges like data quality, infrastructure limitations, and ethical considerations. Addressing these issues is crucial for successful adoption. Ethical challenges related to data privacy and accuracy must also be overcome to ensure better patient understanding, treatment adherence, and improved healthcare outcomes. Continued research, innovation, and collaboration in generative AI have the potential to revolutionize patient education. This can empower patients to make informed decisions about their cardiovascular health, ultimately improving healthcare outcomes in resource-limited settings.

30 October 2025 in Diagnostic and Interventional Imaging
Verified
Journal Article
Open access
BLBenjamin Longère
Benjamin Longère
HCHippolyte Caseneuve
Hippolyte Caseneuve
CGChristos V Gkizas
Christos V Gkizas
AMAimée Rodriguez Musso
Aimée Rodriguez Musso
MTMariia Tregubova
Mariia Tregubova
FPFRANCOIS PONTANA
FRANCOIS PONTANA
The purpose of this study was to evaluate the feasibility and diagnostic performance of stress myocardial perfusion imaging (MPI) using a first-generation dual-source photon-counting CT (PCCT) scanner by comparison with reference standards. Consecutive patients referred for coronary CT angiography (CCTA) with concomitant stress MPI using PCCT scanner and at least one functional reference test within one month were included. Static PCCT-MPI with regadenoson (Rapiscan, GE Healthcare) was acquired 12 s after the intravenous administration of 40 mL of iodinated contrast material and paired with myocardial delayed enhancement imaging. Reference tests for ischemia included stress cardiac magnetic resonance imaging, stress echocardiography, single-photon emission computed tomography, or invasive coronary angiography. Diagnostic performance was evaluated using sensitivity, specificity, accuracy, areas under receiver operating characteristic curve analysis (AUC) as well as Youden index-derived thresholds. Forty-one patients were included. There were 28 men and 13 women with a median age of 62 years (Q1, 57; Q3, 70; range: 18-85 years). Of these, 35 patients (85 %) had obstructive coronary artery disease (CAD) on CCTA. PCCT-MPI identified myocardial hypoperfusion in 18 patients (44 %) with a median dose-length product of 97 mGy.cm (Q1, 76.8; Q3, 155.8). Visual assessment yielded 100 % sensitivity (95 % confidence interval [CI]: 81-100 %) and 96 % specificity (95 % CI: 78-100 %), with an AUC of 0.98 (95 % CI: 0.93-1.00) for the diagnosis of ischemic and infarcted myocardium. An optimal defect-to-remote iodine ratio cutoff of 0.79 showed 98 % accuracy (95 % CI: 87-100 %) and an AUC of 0.99 (95 % CI: 0.98-1.00 %). Integration of PCCT-MPI with CCTA could have obviated additional functional testing or invasive angiography in up to 50 % of patients with obstructive CAD. Stress static PCCT-MPI is feasible and demonstrates excellent diagnostic accuracy for detecting myocardial ischemia. Defect-to-remote iodine ratio from spectral imaging further enhances performance, establishing PCCT as a comprehensive imaging modality that unifies anatomic and functional coronary assessment at a reasonable radiation dose, within a single examination.

1 February 2022 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
KRKostiantyn Rudenko
Kostiantyn Rudenko
VLVasyl V Lazoryshynets
Vasyl V Lazoryshynets
LNLidiia O Nevmerzhytska
Lidiia O Nevmerzhytska
MTMariia O Tregubova
Mariia O Tregubova
PDPolina A Danchenko
Polina A Danchenko
We studied 16 patients after failed alcohol septal ablation who underwent extended septal myectomy to analyse the results of surgical correction and identify technical pitfalls the surgeons may be confronted by. Between October 2017 and March 2019, 16 patients underwent surgical extended septal myectomy with accompanying anomalous secondary chordae resection, papillary muscles mobilization [in 9 (56.3%) patients], and anterior mitral leaflet plication after previously failed alcohol septal ablation. Routine preoperative computed tomography or cardiac magnetic resonance planning and intraoperative transoesophageal echocardiography were performed in each of the studied patients. Major technical features were identified and complemented during septal myectomy of the calcified interventricular septum. The mean age of the studied patients accounted 50.5 ± 14.6, median—54; males—5 (31.3%). Mean cross-clamp time accounted 52 ± 7.2 min. Calcified basal interventricular septum was identified in 2 (12.5%) patients. No iatrogenic ventricular septal defect (0%) was made during surgical correction. Peak systolic pressure gradient decreased from 86 (interquartile range: 75–104.7) to 20 (16–22) mmHg (P< 0.001). No patients with moderate or severe mitral regurgitation were identified, whereas before the procedure, the number of those accounted 13 (81.2%) individuals. In-hospital and overall mortality after septal myectomy accounted 0%. Extended septal myectomy in patients who previously underwent alcohol septal ablation is a safe procedure that affects all pathological manifestations of the disease. Routine preoperative computed tomography or cardiac magnetic resonance provides detailed anatomy of the anomalous left ventricle and subvalvular structures and allows to measure the extension of myectomy preventing the occurrence of iatrogenic ventricular septal defect. Septal myectomy of the calcified interventricular septum requires avoidance of ‘one-piece technique’ since fragmental myectomy allows visually control the adequacy of the left ventricle outflow tract release.

31 May 2024 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
MIM. S. Ishchenko
M. S. Ishchenko
KRKostiantyn Rudenko
Kostiantyn Rudenko
VLV. V. Lazoryshynets
V. V. Lazoryshynets
YVYu. I. Vitkovskyi
Yu. I. Vitkovskyi
MTM. O. Tregubova
M. O. Tregubova
PDP. A. Danchenko
P. A. Danchenko
Hypertrophic cardiomyopathy (HCM) is a prevalent genetic heart disease with a worldwide prevalence. Its estimated incidence in young individuals is approximately 1 case per 500 population. HCM in adults can be clinically diagnosed through visualization, either via 2D echocardiography or cardiac magnetic resonance (CMR) imaging, where the maximum thickness of any left ventricular (LV) segment, measured in end-diastolic phase, is 15 mm in the absence of other hypertrophy causes. Aim. To demonstrate the role and diagnostic capabilities of CMR as a powerful diagnostic tool for detecting and evaluating sudden cardiac death (SCD) risk factors in patients with HCM. Materials and methods. From January 2022 to September 2023, 236 CMR examinations were conducted and analyzed at the Diagnostic Radiology Department of Amosov National Institute of Cardiovascular Surgery in patients with suspected HCM. All examinations were performed on a magnetic resonance tomograph “Toshiba Vantage Titan 1.5T” until May 2023, and “Canon Vantage Orian 1.5T” from May to September 2023, with ECG and respiratory synchronization as well as intravenous injection of gadolinium-based contrast agent (Gadovist 1.0) at a dose of 0.1 mL/kg body weight. Statistical and mathematical data processing was performed by using the Statistica 6.0 (StatSoft Inc., USA) application package. Results. The mean age of the examined patients was 41 ± 28 years, there were 142 male (60 %) and 94 (40 %) female patients. Symmetric non-obstructive HCM was identified in 39 patients (16.5 %) and 184 patients (78.0 %) had asymmetric obstructive HCM. Apical HCM was diagnosed in 4 patients (1.5 %), and midventricular HCM – in 9 patients (4.0 %) including one patient with a combination of midventricular and apical forms. Risk factors for SCD were identified in 60 patients (25.4 %) with myocardial thickness exceeding 30 mm, 8 patients (3.3 %) with apical aneurysm, 4 patients (1.6 %) with reduced LV systolic function (LV ejection fraction <50 %), and 164 patients (69.4 %) with pathological late gadolinium enhancement. Conclusions. CMR is a modern, high-precision and powerful diagnostic method that plays a key role in identifying and assessing SCD risk factors in patients with HCM. CMR helps to identify HCM patients at high SCD risk who may benefit from preventive measures such as implantable cardioverter-defibrillator therapy.

4 March 2021 in e-Journal of Cardiovascular Medicine
Verified
Journal Article
Closed access
RVRostislav M. Vitovsky
Rostislav M. Vitovsky
VIVolodymyr V. Isaіenko
Volodymyr V. Isaіenko
DDDmytro N. Dyadyun
Dmytro N. Dyadyun
VOVolodymyr F. Onishchenko
Volodymyr F. Onishchenko
IMIgor V. Martyshchenko
Igor V. Martyshchenko
OPOlexandr A. Pishchurin
Olexandr A. Pishchurin

1 July 2021 in Zaporozhye Medical Journal
Verified
Journal Article
Open access
PDF file
KRKostiantyn Rudenko
Kostiantyn Rudenko
LNL. O. Nevmerzhytska
L. O. Nevmerzhytska
MKM. V. Kozhanov
M. V. Kozhanov
MTM. О. Tregubova
M. О. Tregubova
PDP. А. Danchenko
P. А. Danchenko
Гипертрофическая кардиомиопатия (ГКМП) – наиболее распространенное генетически детерминированное заболевание сердца, которое характеризуется симметричным или асимметричным утолщением миокарда (≥15 мм), приводит к возникновению прогрессирующей сердечной недостаточности и высокому риску внезапной сердечной смерти (ВСС). Диагностика, естественный ход и лечение ГКМП стали источниками неопределённости, непонимания и дискуссий в связи с растущей сложностью диагностики в клинической практике, международными различиями в стратегических подходах, достижениями в лечении генетических заболеваний и визуализации сердца. Цель работы – дополнить современные представления о ГКМП, патогенезе и механизмах формирования обструкции выходного тракта левого желудочка (ВТ ЛЖ), а также представить собственные результаты хирургической коррекции ГКМП. Материалы и методы. Хирургическая коррекция ГКМП (септальная миэктомия) проведена 330 пациентам на базе ГУ «Национальный институт сердечно-сосудистой хирургии имени Н. Н. Амосова НАМН Украины». Средний возраст пациентов – 49,7 ± 15,0 года, медиана – 53 года, 168 (50,9 %) мужчин. Результаты. Хирургическая коррекция ГКМП позволяет достоверно улучшить качество жизни (у 80 % пациентов отмечен II функциональный класс NYHA после коррекции), уменьшить проявления симптоматики сердечной недостаточности (у 93 % больных установлена минимальная митральная регургитация после септальной миэктомии), снизить систолический градиент давления (СГД) на ВТ ЛЖ (среднее СГД – 18,9 ± 8,5 mmHg, до вмешательства – 93,6 ± 23,2 mmHg) и вывести пациентов из группы высокого риска ВСС (средний процент в группе высокого риска ВСС после коррекции – 3,78 %). Рутинное КТ-планирование и интраоперационная трансэзофагеальная эхокардиография позволяют избежать тяжёлых ятрогенных осложнений и максимально точно выполнить резекцию межжелудочковой перегородки, элиминируя обструкцию ВТ ЛЖ в полном объёме. Выводы. Септальная миэктомия, дополненная резекцией аномальных хордальных прикреплений, мобилизацией папиллярных мышц и пликацией передней створки митрального клапана, позволяет скорректировать все фенотипические проявления этой патологии. Эта безопасная и эффективная процедура – окончательный метод лечения ГКМП, минимизирующий риск рецидива заболевания.